| Detailed information |
|---|
| CancerLivER ID | 2086 |
| Biomarker | Estrone plus Estradiol/Testosterone ratio |
| Biomarker Name/Symbol (given in Publication) | (Estrone+Estradiol)/Testosterone ratio |
| Biomolecule | Steroid |
| Subject | Human |
| Degree of Validity | Potential biomarkers for PLC; but not validated independent dataset |
| Experimental Condition | Normal vs liver cancer |
| Cancer type | Human PLC (primary liver cancer) |
| Regulation | Downregulated in liver cancer cell. |
| Level of significance | p < 0.06 |
| Source | Serum |
| PMID | 27060391 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | Blood samples were collected from 190 participants including 66 early-stage PLC patients, 59 liver cirrhosis patients and 65 healthy volunteers (HV) |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | 0.78 |
| Disease | Human PLC (primary liver cancer) |
| Year of Publication | 2016 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |